CAD was established in the year 2006 in Saudi Arabia and is considered a modern and multi-objective industrial enterprise, designed on the concept of separate manufacturing units, while deploying advanced technical systems for manufacturing high quality Active Pharmaceutical Ingredients (APIs) in consistence. The products of CAD are marketed in the Arab Countries and abroad CAD capital is SAR 266 million, of which ACDIMA owns 25%.
CAD Middle East Pharmaceutical Industries LLC is a state-of-art manufacturing facility using latest technologies with dedication to manufacture the highest quality of Active Pharmaceutical Ingredients (APIs) following current Good Manufacturing Practices (cGMP) standards.
Continuous research and development, consistent high quality following the latest GMP standards, low cost manufacturing of Innovative APIs for our diverse client base. We accomplish this by working in partnership with the clients/partners in understanding their current and future needs.
2006
CAD was established in the year 2006
2013
Started manufacturing activities
The Company's products and production capacity
Offer a wide range of pharmaceutical bulk activities in various therapeutic categories to cater needs of customers across globe
Well experienced technical tream having global pharmaceutical background. GMP compliant warehouses seperate for Raw Materials ,Intermediates and Final APIs, having temperature capabilities from 5 °C to -12 °C . Near to close solid handling from raw materials
The ability to manufacture various APIs, CAD can develop intermediates for other industries e.g. catalysts manufacturing
State-of-the-art multipurpose manufacturing facility having indiviual compartments design concept. Chemical development laboratory to support technology transfer / development. Documentation as per all international regulatory standards.
Contact Information
King Khalid Airport Road, Industrial Estate. Riyadh, Kingdom of Saudi Arabia
_(1).png)
